Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Inge M. Krul"'
Autor:
Nicola S. Russell, Inge M. Krul, Anna M. van Eggermond, Berthe M.P. Aleman, Rosie Cooke, Susanne Kuiper, Steven D. Allen, Matthew G. Wallis, Damien Llanas, Ibrahima Diallo, Florent de Vathaire, Susan A. Smith, Michael Hauptmann, Annegien Broeks, Anthony J. Swerdlow, Flora E. Van Leeuwen
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 7, Iss , Pp 20-27 (2017)
Background: An increased risk of breast cancer following radiotherapy for Hodgkin lymphoma (HL) has now been robustly established. In order to estimate the doseâresponse relationship more accurately, and to aid clinical decision making, a retrospect
Externí odkaz:
https://doaj.org/article/20cd8850c0b447a780edddb7c58bef99
Autor:
Berthe M. P. Aleman, Inge M. Krul, Cécile P. M. Janus, Richard W. M. van der Maazen, Flora E. van Leeuwen
Publikováno v:
Cancer, 129(9), 1455-1456. John Wiley & Sons Inc.
Cancer, 129, 9, pp. 1455-1456
Cancer, 129, 1455-1456
Cancer, 129, 9, pp. 1455-1456
Cancer, 129, 1455-1456
Item does not contain fulltext
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e86fa63b5a429f450441fe87b2b410bc
https://pure.eur.nl/en/publications/589c6b48-048a-4a74-bd3b-af8af1ee615b
https://pure.eur.nl/en/publications/589c6b48-048a-4a74-bd3b-af8af1ee615b
Autor:
Inge M. Krul, Naomi B. Boekel, Iris Kramer, Cécile P. M. Janus, Augustinus D. G. Krol, Marten R. Nijziel, Josée M. Zijlstra, Richard W. M. van der Maazen, Judith M. Roesink, Judy N. Jacobse, Michael Schaapveld, Marjanka K. Schmidt, Annemieke W. J. Opstal‐van Winden, Gabe S. Sonke, Nicola S. Russell, Berthe M. P. Aleman, Flora E. van Leeuwen
Publikováno v:
Krul, I M, Boekel, N B, Kramer, I, Janus, C C P M, Krol, A D G, Nijziel, M R, Zijlstra, J M, van der Maazen, R W M, Roesink, J M, Jacobse, J N, Schaapveld, M, Schmidt, M K, Opstal-van Winden, A W J, Sonke, G S, Russell, N S, Aleman, B M P & van Leeuwen, F E 2022, ' Breast cancer and cardiovascular outcomes after breast cancer in survivors of Hodgkin lymphoma ', Cancer, vol. 128, no. 24, pp. 4285-4295 . https://doi.org/10.1002/cncr.34464
Cancer, 128(24), 4285-4295. John Wiley and Sons Inc.
Cancer, 128, 24, pp. 4285-4295
Cancer, 128(24), 4285-4295. John Wiley & Sons Inc.
Cancer, 128, 4285-4295
Cancer, 128(24), 4285-4295. John Wiley and Sons Inc.
Cancer, 128, 24, pp. 4285-4295
Cancer, 128(24), 4285-4295. John Wiley & Sons Inc.
Cancer, 128, 4285-4295
Item does not contain fulltext BACKGROUND: Hodgkin lymphoma (HL) survivors treated with chest radiotherapy have an increased risk of breast cancer (BC). Prior HL treatment and associated cardiovascular disease (CVD) risk may limit BC treatment option
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18db0c48634e273ea8baca4b4d793795
https://research.vumc.nl/en/publications/13227e25-fb57-473b-a31d-aecdcfc51ed0
https://research.vumc.nl/en/publications/13227e25-fb57-473b-a31d-aecdcfc51ed0
Autor:
Sander Roberti, Flora E van Leeuwen, Cécile M Ronckers, Inge M Krul, Florent de Vathaire, Cristina Veres, Ibrahima Diallo, Cécile P M Janus, Berthe M P Aleman, Nicola S Russell, Michael Hauptmann
Publikováno v:
Journal of the National Cancer Institute, 114(9), 1270-1278. Oxford University Press
Background Breast cancer (BC) risk is increased among Hodgkin lymphoma (HL) survivors treated with chest radiotherapy. Case-control studies showed a linear radiation dose-response relationship for estimated dose to the breast tumor location. However,
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 165
To gain insight into the effect of the coronavirus measures on the number of severe injuries treated at Emergency Departments (EDs).Retrospective observational research.We compared prevalences of ED visits from the Dutch Injury Surveillance System (D
Autor:
A.M. van Eggermond, Michael Hauptmann, Michael Schaapveld, Inge M. Krul, F.E. van Leeuwen, Annegien Broeks, Ausrele Kesminiene, Ibrahima Diallo, Adg Krol, Karen Kooijman, F de Vathaire, M.L. De Bruin, Bmp Aleman, Awj Opstal van Winden, Nicola S. Russell, M.L.M. Lybeert, S Fase, J.M. Zijlstra, Rwm van der Maazen, C.P.M. Janus
Publikováno v:
Cancer Research. 77:P2-06
Background After chest radiotherapy (RT) for Hodgkin lymphoma (HL), women experience a dose-dependent increased breast cancer (BC) risk. It is unknown whether endogenous and exogenous gonadal hormones affect the radiation dose-response relationship.
Autor:
Paul Lips, Michael Hauptmann, Lilian J. Meijboom, Cornelis B. Lambalk, Flora E. van Leeuwen, Berthe M.P. Aleman, Eline van Dulmen-den Broeder, Annemieke W.J. Opstal–van Winden, Erik H. Serné, Laurien A. Daniëls, Inge M. Krul, Yolande Appelman, Sanne B. Schagen, Josée M. Zijlstra
Publikováno v:
BMJ Open, 8(9). BMJ Publishing Group
BMJ Open, 8(9)
BMJ open, 8(9). BMJ Publishing Group
Krul, I M, Opstal-van Winden, A W J, Zijlstra, J M, Appelman, Y, Schagen, S B, Meijboom, L J, Serné, E, Lambalk, C B, Lips, P, van Dulmen-den Broeder, E, Hauptmann, M, Daniëls, L A, Aleman, B M P & van Leeuwen, F E 2018, ' Rationale and design of a cohort study on primary ovarian insufficiency in female survivors of Hodgkin's lymphoma : influence on long-term adverse effects (SOPHIA) ', BMJ Open, vol. 8, no. 9, pp. e018120 . https://doi.org/10.1136/bmjopen-2017-018120
BMJ Open, 8(9):e018120. BMJ Publishing Group
BMJ Open, 8(9)
BMJ open, 8(9). BMJ Publishing Group
Krul, I M, Opstal-van Winden, A W J, Zijlstra, J M, Appelman, Y, Schagen, S B, Meijboom, L J, Serné, E, Lambalk, C B, Lips, P, van Dulmen-den Broeder, E, Hauptmann, M, Daniëls, L A, Aleman, B M P & van Leeuwen, F E 2018, ' Rationale and design of a cohort study on primary ovarian insufficiency in female survivors of Hodgkin's lymphoma : influence on long-term adverse effects (SOPHIA) ', BMJ Open, vol. 8, no. 9, pp. e018120 . https://doi.org/10.1136/bmjopen-2017-018120
BMJ Open, 8(9):e018120. BMJ Publishing Group
IntroductionHodgkin’s lymphoma (HL) has become the prototype of a curable disease. However, many young survivors suffer from late adverse effects of treatment. Both chemotherapy (CT) and radiotherapy (RT) may induce primary ovarian insufficiency (P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1dbd6e41b26254fbe0284ac7396748e2
https://doi.org/10.1136/bmjopen-2017-018120
https://doi.org/10.1136/bmjopen-2017-018120
Autor:
Flora E. van Leeuwen, Katarzyna Jozwiak, Annemieke W.J. Opstal–van Winden, Berthe M.P. Aleman, Laurien A. Daniëls, Simone de Vries, Angela H.E.M. Maas, Inge M. Krul, Cecile P.M. Janus, Michael Hauptmann, Rianne Van Nimwegen
Publikováno v:
Journal of Clinical Oncology, 36(7)
114 Background: Female survivors of Hodgkin lymphoma (HL) treated with alkylating chemotherapy (CT) and/or pelvic radiotherapy (RT) have an increased risk of primary ovarian insufficiency (POI). Among women with a natural menopause, POI has been asso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3887f6130e65cc70a26e8891afcf2172
https://hdl.handle.net/1887/96380
https://hdl.handle.net/1887/96380
Autor:
T.M. Mooij, Michael Hauptmann, Peter G.A. Hompes, Curt W. Burger, Jos W. R. Twisk, F.E. van Leeuwen, Mandy Spaan, E. Groeneveld, Inge M. Krul, A.W. van den Belt-Dusebout, M.J. Lambers, C.B. Lambalk
Publikováno v:
European Journal of Cancer, 51(1), 112-120. Elsevier Limited
Krul, I M, Groeneveld, E, Spaan, M, van den Belt-Dusebout, A, Mooij, T M, Hauptmann, M, Twisk, J W R, Lambers, M J, Hompes, P G A, Burger, C W, Lambalk, C B & van Leeuwen, F E 2015, ' Increased breast cancer risk in in vitro fertilisation treated women with a multiple pregnancy: A new hypothesis based on historical in vitro fertilisation treatment data ', European Journal of Cancer, vol. 51, no. 1, pp. 112-120 . https://doi.org/10.1016/j.ejca.2014.10.018
European Journal of Cancer, 51(1), 112-120. Pergamon
European Journal of Cancer, 51(1), 112-120. Elsevier Ltd.
Krul, I M, Groeneveld, E, Spaan, M, van den Belt-Dusebout, A, Mooij, T M, Hauptmann, M, Twisk, J W R, Lambers, M J, Hompes, P G A, Burger, C W, Lambalk, C B & van Leeuwen, F E 2015, ' Increased breast cancer risk in in vitro fertilisation treated women with a multiple pregnancy: A new hypothesis based on historical in vitro fertilisation treatment data ', European Journal of Cancer, vol. 51, no. 1, pp. 112-120 . https://doi.org/10.1016/j.ejca.2014.10.018
European Journal of Cancer, 51(1), 112-120. Pergamon
European Journal of Cancer, 51(1), 112-120. Elsevier Ltd.
Background: Breast cancer risk is temporarily increased after a full-term pregnancy and declines thereafter, possibly due to increased levels of gonadal and placental hormones during pregnancy. Inconsistent results, however, have been reported after
Autor:
Rosie Cooke, Michael Hauptmann, Anna M. van Eggermond, Matthew G. Wallis, Ibrahima Diallo, Steven D. Allen, Annegien Broeks, Florent de Vathaire, Berthe M.P. Aleman, Flora E. van Leeuwen, Susan A. Smith, Anthony J. Swerdlow, Damien Llanas, Inge M. Krul, Susanne Kuiper, Nicola S. Russell
Publikováno v:
Clinical and Translational Radiation Oncology
Clinical and Translational Radiation Oncology, Vol 7, Iss, Pp 20-27 (2017)
Clinical and Translational Radiation Oncology, Vol 7, Iss, Pp 20-27 (2017)
Background: An increased risk of breast cancer following radiotherapy for Hodgkin lymphoma (HL) has now been robustly established. In order to estimate the doseâresponse relationship more accurately, and to aid clinical decision making, a retrospect